CONFLICT OF INTEREST
Diabetes
DIABETES
Zoltan J. Taybani received honoraria for speaking at meetings from Novo Nordisk, Sanofi, Eli Lilly, AstraZeneca, Boehringer Ingelheim and Novartis, Balázs Bótyik; received honoraria for speaking at meetings from Novo Nordisk, Sanofi, Eli Lilly, AstraZeneca, Boehringer Ingelheim and Novartis, Mónika Katkó and András Gyimesi have nothing to disclose. András Gyimesi has passed away. Tamás Várkonyi received honoraria for speaking at meetings from Novo Nordisk, Sanofi, Eli Lilly, AstraZeneca, Boehringer Ingelheim, Wörwag Pharma and Novartis. The results of the trial were presented as an oral presentation at the 14th International Conference on Diabetes Technologies & Treatments, 2–5 June, 2021, and the abstract was published in Diabetes Technology and Therapeutics, 2021, 23(S2):A54‐55, DOI: 